Comments
Analysis: U.S. foreign bribery penalties for drugmakers may lack bite
30.10.2012. | NEW YORK (Reuters) - Global drugmakers are paying tens of millions of dollars to settle U.S. allegations that they bribed their way across emerging markets, but harsher penalties may be needed to deter the practice in untapped regions where billions are at stake....
